A double-blind clinical study of bufexamac and fluocinolone acetonide in dermatitis.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000188:drug therapy*; D004341:Drug Evaluation; D005446:Fluocinolone Acetonide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D010648:Phenylacetates / Q000009:adverse effects / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D010648:Phenylacetates; D005446:Fluocinolone Acetonide